[HTML][HTML] The preventive effect of antiplatelet therapy in acute respiratory distress syndrome: a meta-analysis
Y Wang, M Zhong, Z Wang, J Song, W Wu, D Zhu - Critical Care, 2018 - Springer
Background Acute respiratory distress syndrome (ARDS) is a life-threatening condition with
high mortality that imposes a serious medical burden. Antiplatelet therapy is a potential …
high mortality that imposes a serious medical burden. Antiplatelet therapy is a potential …
[HTML][HTML] Antiplatelet therapy and the outcome of subjects with intracranial injury: the Italian SIMEU study
A Fabbri, F Servadei, G Marchesini, C Bronzoni… - Critical care, 2013 - Springer
Introduction Pre-injury antithrombotic therapy might influence the outcome of subjects
withhead injuries and positive computed tomography (CT) scans. We aimed to determinethe …
withhead injuries and positive computed tomography (CT) scans. We aimed to determinethe …
Risk factors for the development of acute lung injury in patients with septic shock: an observational cohort study
Methods An observational cohort study in a medical ICU in a tertiary medical center. Patients
were prospectively identified with septic shock who did not have ALI at the outset, excluding …
were prospectively identified with septic shock who did not have ALI at the outset, excluding …
[HTML][HTML] Effect of total cholesterol and statin therapy on mortality in ARDS patients: a secondary analysis of the SAILS and HARP-2 trials
SM Pienkos, AR Moore, J Guan, JE Levitt, MA Matthay… - Critical Care, 2023 - Springer
Background Two acute respiratory distress syndrome (ARDS) trials showed no benefit for
statin therapy, though secondary analyses suggest inflammatory subphenotypes may have …
statin therapy, though secondary analyses suggest inflammatory subphenotypes may have …
[HTML][HTML] Outcome of acute respiratory distress syndrome in university and non-university hospitals in Germany
K Raymondos, T Dirks, M Quintel, U Molitoris, J Ahrens… - Critical Care, 2017 - Springer
Background This study investigates differences in treatment and outcome of ventilated
patients with acute respiratory distress syndrome (ARDS) between university and non …
patients with acute respiratory distress syndrome (ARDS) between university and non …
[HTML][HTML] Ventilator-associated pneumonia and ICU mortality in severe ARDS patients ventilated according to a lung-protective strategy
JM Forel, F Voillet, D Pulina, A Gacouin, G Perrin… - Critical Care, 2012 - Springer
Introduction Ventilator-associated pneumonia (VAP) may contribute to the mortality
associated with acute respiratory distress syndrome (ARDS). We aimed to determine the …
associated with acute respiratory distress syndrome (ARDS). We aimed to determine the …
Impact of treatment with pravastatin on delayed ischemic disease and mortality after aneurysmal subarachnoid hemorrhage
U Jaschinski, K Scherer, M Lichtwarck, H Forst - Critical Care, 2008 - Springer
Methods A total of 98 patients (20–80 years old) with aSAH were randomized to receive
either pravastatin 40 mg (n= 40) or nonstatin treatment (n= 58) within 24 hours after the ictus …
either pravastatin 40 mg (n= 40) or nonstatin treatment (n= 58) within 24 hours after the ictus …
[HTML][HTML] Causes and attributable fraction of death from ARDS in inflammatory phenotypes of sepsis
Background Hypoinflammatory and hyperinflammatory phenotypes have been identified in
both Acute Respiratory Distress Syndrome (ARDS) and sepsis. Attributable mortality of …
both Acute Respiratory Distress Syndrome (ARDS) and sepsis. Attributable mortality of …
[HTML][HTML] Comparative efficacy of vasoactive medications in patients with septic shock: a network meta-analysis of randomized controlled trials
L Cheng, J Yan, S Han, Q Chen, M Chen, H Jiang, J Lu - Critical care, 2019 - Springer
Background Catecholamines, especially norepinephrine, are the most frequently used
vasopressors for treating patients with septic shock. During the recent decades, terlipressin …
vasopressors for treating patients with septic shock. During the recent decades, terlipressin …
[HTML][HTML] Identification of distinct clinical phenotypes of acute respiratory distress syndrome with differential responses to treatment
X Liu, Y Jiang, X Jia, X Ma, C Han, N Guo, Y Peng… - Critical Care, 2021 - Springer
Background Acute respiratory distress syndrome (ARDS) is a heterogeneous syndrome, and
the identification of homogeneous subgroups and phenotypes is the first step toward …
the identification of homogeneous subgroups and phenotypes is the first step toward …